CD

Carl Decicco

Pharmaceutical Executive

New Hope, Pennsylvania

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $500,000.00

  • Max Investment:

    $15,000,000.00

  • Target Investment:

    $7,000,000.00

Skills

Medicinal Chemistry
Drug Discovery
Organic Chemistry
Drug Development
Pharmaceutical Industry
Drug Design
Clinical Development
Chemistry
Biotechnology
Oncology
Technology Transfer
CRO
Lifesciences
Analytical Chemistry
Lead Change
Organic Synthesis
Pharmacology
Translational Medicine
Parallel Synthesis
R&D

Education

Work Experience

Flagship Pioneering

2018

  • Partner

    2018

Foghorn Therapeutics, Inc

2018 - 2022

  • Chief Scientific Officer

    2018 - 2022

Bristol-Myers Squibb

2013 - 2018

  • Senior Vice President, Head of Discovery

    2013 - 2018

Bristol-Myers Squibb

2002 - 2013

  • Senior Vice President, Molecular Sciences

    2010 - 2013

  • Vice President, Discovery Chemistry/Molecular Sciences

    2002 - 2010